1-3 of 3
Angelica Caramanica
Close
Sort by
Journal Articles

Efficacy and Safety of Hydroxychloroquine Sulphate In Chronic Lymphocytic Leukemia: Clinical Trial Experience In Untreated Patients

Shih-Shih Chen, Ph.D., Matthew Kaufman, M.D., Angelica Caramanica, Rajendra N Damle, Ph.D., Peter Garofalo, Patricia Ly, Dale Janson, Steven L. Allen, M.D., Jonathan Kolitz, M.D., Linda Quill, Kanti R. Rai, M.D., Nicholas Chiorazzi, M.D.
Journal: Blood
Blood (2010) 116 (21): 1392.
https://doi.org/10.1182/blood.V116.21.1392.1392
Published: 2010
Journal Articles

Surprising Lack of Correlation between CD38 and Time to First Treatment in Chronic Lympocytic Leukemia.

Matthew S. Kaufman, MD, Rajendra Damle, PhD, Nina Kohn, MA, Christina Johnson, RPA-C, Nancy Driscoll, RPA-C, Angelica Caramanica, RPA-C, Yehuda Lebowicz, MD, Kai Tsao, MD, Nicholas Chiorazzi, MD, Kanti Rai, MD
Journal: Blood
Blood (2007) 110 (11): 2058.
https://doi.org/10.1182/blood.V110.11.2058.2058
Published: 2007
Journal Articles

A Combination of Rituxan, Cyclophosphamide and Dexamethasone (RCD) Results in Long-Lasting Responses in Autoimmune Anemia and Thrombocytopenia in CLL Patients: A Single Institution Study.

Matthew S. Kaufman, MD, Yehuda Z. Lebowicz, MD, Nancy Driscoll, RPA-C, Christina Johnson, RPA-C, Dale Janson, RPA-C, Angelica Caramanica, RPA-C, Rajasree Roy, MD, Neetu Radhakrishnan, MD, Dhaval Mehta, MD, Mark Hoffman, MD, Dilip Patel, MD, Nina Kohn, MBA,MA, Kanti R. Rai, MD
Journal: Blood
Blood (2006) 108 (11): 2832.
https://doi.org/10.1182/blood.V108.11.2832.2832
Published: 2006